Emily Baynham, RN | |
1199 Prince Ave, Athens, GA 30606-2797 | |
(706) 425-7000 | |
Not Available |
Full Name | Emily Baynham |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 1199 Prince Ave, Athens, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780350066 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | RN258077 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Emily Baynham, RN 4250 Wild Indigo Xing, Statham, GA 30666-3355 Ph: () - | Emily Baynham, RN 1199 Prince Ave, Athens, GA 30606-2797 Ph: (706) 425-7000 |
News Archive
A person is 100 times more likely to get cancer at age 65 than at age 35. But new research reported in the journal "Nature Genetics" identifies naturally occurring processes that allow many genes to both slow aging and protect against cancer in the much-studied C. elegans roundworm.
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its PinAAcle™ series atomic absorption spectrometers for determining the concentration of inorganic elements in a wide variety of sample types.
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.
That internal nagging feeling that drives you to seek sleep at night and wake in the morning to eat, work, and play, is, it turns out, genetic, and it's not just in people.
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces the peer-reviewed publication of the primary outcome results of the Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid ChemoTherapy (MINDACT) clinical trial in the prestigious New England Journal of Medicine (NEJM). (i, iii, iv) The publication demonstrates that 46% of breast cancer patients considered for chemotherapy, whose tumors are classified MammaPrint Low Risk, have excellent survival without chemotherapy, and can thus be candidates to avoid this toxic therapy.
› Verified 7 days ago
Fanie Wehmanen, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 Mitchell Bridge Rd, Athens, GA 30606 Phone: 706-612-6995 Fax: 706-369-6328 | |
Janet Robison Avant, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-9739 | |
Marjorie Spencer, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-9700 Fax: 706-227-7249 | |
Mr. Vito Cortese Jr., RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 Mitchell Bridge Rd, Athens, GA 30606 Phone: 855-333-9544 | |
Richard Cereneche, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 195 Miles St, Athens, GA 30601 Phone: 706-542-9700 Fax: 706-227-7249 | |
Mary Donna Hall, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-0333 Fax: 706-542-9693 | |
Tiny Stephens, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 675 College Ave, Athens, GA 30601 Phone: 706-546-5526 |